Cargando…

Role of Asxl2 in non-alcoholic steatohepatitis-related hepatocellular carcinoma developed from diabetes

The present study investigated the mechanism(s) of non-alcoholic steatohepatitis-related hepatocellular carcinoma (NASH-HCC) developed from diabetes. Streptozotocin and a high-fat diet (STZ-HFD) were used to induce NASH-HCC in ApoE(−/−) mice. Mouse liver functions were evaluated by H&E staining,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zhiqiu, Zhang, Ziping, Teng, Fei, Feng, Jinfeng, Wu, Xubo, Chang, Qimeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723516/ https://www.ncbi.nlm.nih.gov/pubmed/33155659 http://dx.doi.org/10.3892/ijmm.2020.4782

Ejemplares similares

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
por: Kumar, Rahul, et al.
Publicado: (2020)

SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma
por: Chang, Qimeng, et al.
Publicado: (2021)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
por: Ramai, Daryl, et al.
Publicado: (2021)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
por: Yu, Junjie, et al.
Publicado: (2023)

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
por: Shiina, Shuichiro, et al.
Publicado: (2023)

Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
por: Ip, Blanche C., et al.
Publicado: (2013)

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014)

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
por: Weinmann, Arndt, et al.
Publicado: (2015)

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
por: Cholankeril, George, et al.
Publicado: (2017)

Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
por: Liakina, Valentina, et al.
Publicado: (2022)

Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin
por: Xu, Yayun, et al.
Publicado: (2023)

Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas
por: Kakehashi, Anna, et al.
Publicado: (2017)

A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Krizanac, Marinela, et al.
Publicado: (2021)

All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma
por: van Mourik, Hester, et al.
Publicado: (2022)

Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2019)

13 CHEMOPREVENTIVE EFFECT OF STATIN ON HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH CIRRHOSIS
por: Al-Yaman, Wael A., et al.
Publicado: (2021)

Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
por: Hymel, Emma, et al.
Publicado: (2022)

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases
por: Safaei, Akram, et al.
Publicado: (2016)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

p27 Is a Critical Prognostic Biomarker in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma
por: Matsuda, Yasunobu, et al.
Publicado: (2013)

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis – epidemiology, risk factors, clinical implications and treatment
por: Straś, Wojciech, et al.
Publicado: (2020)

Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma
por: Jacques, Sophie, et al.
Publicado: (2021)

Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma
por: Chan, Landon L., et al.
Publicado: (2022)

Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics
por: Sydor, Svenja, et al.
Publicado: (2022)

Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
por: Ocker, Matthias
Publicado: (2020)

Impact of Type 2 Diabetes on Oncologic Outcomes of Hepatocellular Carcinomas in Non-Cirrhotic, Non-alcoholic Steatohepatitis: a Matched-Pair Analysis
por: Billeter, Adrian T., et al.
Publicado: (2020)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response
por: Simoes Eugénio, Mélanie, et al.
Publicado: (2020)

Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
por: Tian, Ying, et al.
Publicado: (2020)

Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
por: Kuo, Joseph, et al.
Publicado: (2019)

Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non‐alcoholic steatohepatitis model
por: Shimizu, Yoshio, et al.
Publicado: (2020)

A new preclinical model of western diet‐induced progression of non‐alcoholic steatohepatitis to hepatocellular carcinoma
por: Green, Christopher D., et al.
Publicado: (2022)

Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma
por: Tian, Zelin, et al.
Publicado: (2022)

Research landscape and frontiers of non-alcoholic steatohepatitis-associated hepatocellular carcinoma: a bibliometric and visual analysis
por: Gao, Bowen, et al.
Publicado: (2023)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

RORγt inhibitor SR1001 alleviates acute pancreatitis by suppressing pancreatic IL‐17‐producing Th17 and γδ‐T cells in mice with ceruletide‐induced pancreatitis
por: Wang, Jianfa, et al.
Publicado: (2021)

Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice
por: Yamada, Shoji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mgs0kia779khpaiaaduqblc0iv